Helene Vioix is an experienced associate currently serving as the Director of HTA - Value and Access International, focusing on Diabetes Obesity at Eli Lilly and Company. They have a demonstrated history of working in the pharmaceuticals industry, including roles as a Senior Health Economist at Boehringer Ingelheim and Associate Director of Global Evidence & Value Development Oncology at Merck KGaA. Helene's expertise encompasses Vaccines, Psychiatry, Modeling, Health Economics, and Infection. Helene earned a Master’s degree in Economic Evaluation in Healthcare from City St George’s, University of London, and is pursuing a PharmD at Université Paris Sud (Paris XI).
This person is not in the org chart
This person is not in any teams
This person is not in any offices